Medicare Enrolled
Kiren Sahni
Rheumatology · West Long Branch, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Sahni from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Sahni?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Sahni
Kiren Sahni is a rheumatology specialist in West Long Branch, NJ, with 12 years of NPI registration. Based on federal Medicare data, Sahni performed 174,520 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Sahni received a total of $415,584 from 48 pharmaceutical and/or device companies across 1679 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Sahni is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years of NPI registration
▲ Top 2% volume in NJ
$415,584 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗174,520
Medicare services
Top 2% in NJ for rheumatology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
112,400 | $4 | $16 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
45,549 | $10 | $42 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
11,675 | $33 | $131 |
| Denosumab injection (Prolia/Xgeva) | 2,340 | $18 | $70 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
468 | $115 | $472 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
392 | $64 | $261 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
328 | $12 | $32 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
325 | $100 | $237 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
299 | $72 | $165 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
220 | $85 | $250 |
| Injection, methylprednisolone acetate, 40 mg | 205 | $6 | $30 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
154 | $130 | $358 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
94 | $213 | $2,600 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
44 | $84 | $210 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
16 | $182 | $511 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $35 | $236 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
33.1% high complexity
66.3% medium
0.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$415,584
Total received (2018-2024)
Avg $59,369/year across 7 years
Top 1% in NJ for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
1,679
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$209,155
2023
$88,655
2022
$74,978
2021
$32,321
2020
$7,556
2019
$966
2018
$1,952
Payments by company (2024)
Amgen Inc.
$91,484
ABBVIE INC.
$61,423
Janssen Biotech, Inc.
$28,560
AstraZeneca Pharmaceuticals LP
$12,071
GlaxoSmithKline, LLC.
$6,295
PFIZER INC.
$4,923
E.R. Squibb & Sons, L.L.C.
$3,072
Novartis Pharmaceuticals Corporation
$303
Aurinia Pharma U.S., Inc.
$185
UCB, Inc.
$162
Genentech USA, Inc.
$139
Alexion Pharmaceuticals, Inc.
$84
Radius Health, Inc.
$60
ANI Pharmaceuticals, Inc.
$59
Kiniksa Pharmaceuticals International, plc
$58
Fresenius Kabi USA, LLC
$50
Lilly USA, LLC
$47
GENZYME CORPORATION
$33
Abbott Laboratories
$32
DePuy Synthes Sales Inc.
$30
Bioventus LLC
$25
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
SCILEX PHARMACEUTICALS INC.
$16
Kyowa Kirin, Inc.
$15
Mallinckrodt Hospital Products Inc.
$14
Top 3 companies account for 86.8% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$97,637
ABBVIE INC.
$89,498
Janssen Biotech, Inc.
$43,492
Horizon Therapeutics plc
$42,795
GlaxoSmithKline, LLC.
$35,914
AbbVie Inc.
$30,647
PFIZER INC.
$29,221
AstraZeneca Pharmaceuticals LP
$18,118
Janssen Scientific Affairs, LLC
$9,100
E.R. Squibb & Sons, L.L.C.
$5,492
UCB, Inc.
$5,030
Aurinia Pharma U.S., Inc.
$4,136
Novartis Pharmaceuticals Corporation
$905
Lilly USA, LLC
$478
Genentech USA, Inc.
$462
Boehringer Ingelheim Pharmaceuticals, Inc.
$286
ANI Pharmaceuticals, Inc.
$271
Mallinckrodt Hospital Products Inc.
$263
GENZYME CORPORATION
$214
Exeltis, USA Inc.
$193
AbbVie, Inc.
$166
DePuy Synthes Sales Inc.
$140
Horizon Pharma plc
$136
CVRx, Inc.
$128
Alexion Pharmaceuticals, Inc.
$126
Radius Health, Inc.
$117
Sobi, Inc
$69
Kiniksa Pharmaceuticals International, plc
$58
Celgene Corporation
$57
Fresenius Kabi USA, LLC
$50
SANOFI-AVENTIS U.S. LLC
$45
Bioventus LLC
$38
Abbott Laboratories
$32
Orthogenrx Inc.
$32
Kiniksa Pharmaceuticals, Ltd.
$31
Flexion Therapeutics, Inc.
$26
Collegium Pharmaceutical, Inc.
$24
SI-BONE, INC.
$23
SCILEX PHARMACEUTICALS INC.
$16
Organon LLC
$16
Kyowa Kirin, Inc.
$15
Antares Pharma, Inc.
$15
Egalet US Inc
$14
Avanos Medical
$12
Ferring Pharmaceuticals Inc.
$12
Purdue Pharma L.P.
$12
Zyla Life Sciences
$12
FIDIA PHARMA USA INC.
$10
Top 3 companies account for 55.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIMMUNE · Actemra · Aimovig · Arcalyst · BENLYSTA · Barostim Neo System · COSENTYX · CYLTEZO · Cimzia · Crysvita · Durolane · ELIQUIS · ETERNA · EUCRISA · EUFLEXXA · EVENITY · Enbrel · FASENRA · GELSYN-3 · HUMIRA · Humira · Hymovis · IFUSE IMPLANT · ILARIS · KEVZARA · KRYSTEXXA · Kineret · LUPKYNIS · Nucynta · OFEV · OLUMIANT · ORENCIA · ORTHOVISC · Otezla · Otrexup · PENNSAID · PRADAXA · PROCLAIM · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Repatha · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · STRENSIQ · SYMPROIC · SYNVISC · SYNVISC-ONE · Sotyktu · Strensiq · TALTZ · TAVNEOS · TREMFYA · TRIVISC SODIUM HYALURONATE · Tavneos · TriVisc sodium hyaluronate · Tyenne · Tymlos · XELJANZ · XTAMPZA · ZTLido · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
56
County median income
$122,727
Nearest hospital to ZIP centroid (approximate)
MONMOUTH MEDICAL CENTER
1.7 mi
1.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Sahni is a mixed practice specialist, with above-average Medicare volume (top 2% in NJ).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Sahni experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Sahni performed 112,400 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Sahni receive payments from pharmaceutical companies?
Yes. Sahni received a total of $415,584 from 48 companies across 1,679 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Sahni's costs compare to other rheumatologists in West Long Branch?
Sahni's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Sahni) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in West Long Branch
Browse rheumatologists in West Long Branch ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in NJ
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in NJ
Which NJ rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology